These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Kern TS; Engerman RL Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392 [TBL] [Abstract][Full Text] [Related]
4. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Frank RN; Amin R; Kennedy A; Hohman TC Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Kowluru RA; Tang J; Kern TS Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058 [TBL] [Abstract][Full Text] [Related]
6. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301 [TBL] [Abstract][Full Text] [Related]
10. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396 [TBL] [Abstract][Full Text] [Related]
11. A central role for inflammation in the pathogenesis of diabetic retinopathy. Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732 [TBL] [Abstract][Full Text] [Related]
12. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. Kern TS; Engerman RL Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891 [TBL] [Abstract][Full Text] [Related]
13. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169 [TBL] [Abstract][Full Text] [Related]
14. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Kowluru RA Curr Eye Res; 2002 Feb; 24(2):123-8. PubMed ID: 12187484 [TBL] [Abstract][Full Text] [Related]
15. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416 [TBL] [Abstract][Full Text] [Related]
16. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Tang J; Mohr S; Du YD; Kern TS Curr Eye Res; 2003 Jul; 27(1):7-13. PubMed ID: 12868004 [TBL] [Abstract][Full Text] [Related]
17. Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. Berkowitz BA; Ito Y; Kern TS; McDonald C; Hawkins R Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2964-9. PubMed ID: 11687543 [TBL] [Abstract][Full Text] [Related]
19. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats. Roy S; Lorenzi M Diabetologia; 1996 Jun; 39(6):735-8. PubMed ID: 8781771 [TBL] [Abstract][Full Text] [Related]
20. Pericytes and the pathogenesis of diabetic retinopathy. Hammes HP; Lin J; Renner O; Shani M; Lundqvist A; Betsholtz C; Brownlee M; Deutsch U Diabetes; 2002 Oct; 51(10):3107-12. PubMed ID: 12351455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]